Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy®, begins treatment at a dose of 0.25 milligrams administered subcutaneously once weekly. This conservative starting point allows your digestive system and metabolism to adjust while minimizing side effects. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies across all 50 states, with pricing that stays flat as your clinical dose increases.
Understanding Semaglutide Starting Doses and Titration Schedules
The standard semaglutide initiation protocol uses a gradual dose escalation over 16 weeks. Week one begins at 0.25 mg weekly, advancing to 0.5 mg in week five, then 1.0 mg in week nine, and reaching 1.7 mg by week thirteen if tolerated. This step-wise approach mirrors clinical trial design and matches how FDA-evaluated weight loss programs introduce the medication. The incremental increases give your appetite-regulating pathways time to respond without overwhelming your system.
Your body's response to each dose level varies based on individual factors including metabolic rate, gastrointestinal sensitivity, and genetic predispositions affecting GLP-1 receptor function. Some patients reach meaningful weight loss at lower maintenance doses around 1.0 mg weekly, while others benefit from the full 2.4 mg target dose. PlexusDx personalizes your escalation timeline and target dose through clinical assessment and optional Precision Peptide Genetic Testing, which examines 14 metabolic pathways including your GLP1R rs6923761 variant that influences receptor sensitivity.
Why Low-Dose Initiation Reduces Nausea and Side Effects
Starting at 0.25 mg minimizes gastrointestinal side effects that can occur when semaglutide rapidly activates GLP-1 receptors in your gut. Nausea, vomiting, and constipation are more common at higher initial doses because these receptors regulate stomach emptying and appetite signaling simultaneously. By beginning low and advancing gradually, your digestive tract adapts to the medication's effects, making tolerability much higher long-term. Real-world data shows that approximately 70% of patients experience only mild side effects when following proper dose escalation, compared to 40% experiencing moderate effects with faster titration.
Gradual dosing also allows you to distinguish between expected appetite reduction and problematic nausea. Legitimate appetite suppression—eating less and feeling satisfied sooner—is the therapeutic goal. Nausea unrelated to food intake suggests your dose is advancing too quickly. Your PlexusDx clinician monitors this distinction and can slow your escalation or adjust timing between dose increases if needed, ensuring your treatment feels manageable while remaining effective.
Dose Adjustments Based on Individual Metabolic Response
Not every patient needs the maximum 2.4 mg dose to achieve meaningful weight loss. Clinical outcomes depend on your starting weight, metabolic rate, lifestyle factors, and how your specific genetic variants affect peptide signaling. Patients with certain GLP1R polymorphisms may experience robust appetite suppression at 1.0 or 1.7 mg, while others with different genetic profiles might benefit from continuing to 2.4 mg. The Precision Peptide Genetic Test evaluates your FTO rs9939609 and MC4R rs17782313 variants, both associated with baseline hunger drive, to help identify your likely therapeutic dose window.
Weight loss velocity itself guides dose decisions. Losing 1-2% of body weight per week indicates optimal dosing; faster loss may suggest your current dose is sufficient, while slower loss might warrant continued escalation. PlexusDx clinicians review your monthly progress and adjust your next dose tier accordingly. Your price remains $149 per month for compounded semaglutide injections regardless of whether you're at the 0.5 mg starter phase or your final therapeutic dose—ensuring predictable costs as your treatment evolves.
Cost-Effective Semaglutide Starting at $149 Monthly
PlexusDx compounded semaglutide injections start at $149 per month and remain that price through all dose levels and tiers. Unlike brand-name Wegovy® or insurance-dependent programs, PlexusDx eliminates membership fees, insurance requirements, and surprise cost increases as your dose advances. All medications come from licensed 503A compounding pharmacies verified for quality and sterility. HSA and FSA accounts are accepted, providing additional tax-advantaged flexibility for your weight management investment.
Accessing semaglutide through PlexusDx involves a simple telehealth consultation with a clinician, a baseline assessment, and prescription delivery to your home. There are no membership tiers that affect medication access—only optional commitment options that provide consistency in pricing and supply. If you're considering genetic testing to optimize your personalized protocol, the Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, giving you detailed insights into your 14 metabolic pathways and 150+ genetic factors influencing GLP-1 response.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the exact starting dose of semaglutide for weight loss?
Semaglutide therapy begins at 0.25 mg administered subcutaneously once per week. This low initial dose allows your body to adapt safely before escalating through weeks 5, 9, and 13 to higher therapeutic doses. PlexusDx clinicians guide your personalized escalation schedule based on your tolerability and weight loss response.
How long does the semaglutide dose escalation phase last?
The standard escalation protocol spans 16 weeks, increasing your dose every four weeks from 0.25 mg to a target maintenance dose between 1.0 mg and 2.4 mg weekly. Clinical trials demonstrate this gradual approach produces superior long-term weight loss and tolerability compared to faster titration schedules.
Does my PlexusDx price increase when my semaglutide dose goes up?
No. PlexusDx compounded semaglutide injections start at $149 per month and your price remains flat regardless of dose increases or tier selection. You pay one predictable monthly cost as your clinical dose advances, with no surprise charges for higher doses.
What side effects should I expect when starting semaglutide at 0.25 mg?
Most patients starting at 0.25 mg experience minimal side effects because the dose is conservative. Mild nausea or decreased appetite are common initial responses; they typically resolve within a few days as your body adjusts. Severe nausea at this dose level suggests slower escalation may be needed—PlexusDx clinicians adjust your timeline to ensure comfortable, sustainable treatment.
How can PlexusDx's Precision Peptide Genetic Test help optimize my starting semaglutide dose?
The Precision Peptide Genetic Test ($99 add-on after month one) analyzes your GLP1R rs6923761 variant plus 13 other metabolic pathways to predict how your body responds to semaglutide. Patients with certain genetic profiles may reach therapeutic benefit at lower doses, while others may benefit from advancing more quickly to higher doses. This personalization increases your likelihood of finding your optimal dose within your first 16 weeks.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Ozempic: Uses, Side Effects, and Management Strategies
Why Ozempic and Wegovy Seem to Treat Everything